M-M-R II Shortage Update: What Patients Need to Know in 2026

If you have been trying to get the M-M-R II vaccine and hitting dead ends at pharmacies, you are not imagining the problem. Reports of M-M-R II being unavailable — or very hard to find — have been widespread since early 2025 and continue into 2026 in some regions. This article gives you the current state of MMR vaccine availability, explains what happened, and tells you exactly what to do.

Is There an Official M-M-R II Shortage in 2026?

As of 2026, there is no declared national manufacturing shortage of M-M-R II. Merck has not reported any interruption to production, and the FDA has not placed M-M-R II on its official drug shortage list. What has occurred are localized, demand-driven spot shortages — primarily in commercial pharmacy channels — that resulted from an unprecedented surge in demand during the 2025 measles outbreaks.

The distinction matters. A manufacturing shortage means there is not enough vaccine being produced. A demand-driven spot shortage means the vaccine exists — but distribution cannot keep pace with a sudden spike in requests at specific commercial locations. The good news is that spot shortages typically resolve faster than manufacturing shortages.

What Triggered the Shortages?

The 2025 measles outbreak — concentrated in western Texas and New Mexico but with cases spreading to multiple states — was the primary trigger. Measles spreads very rapidly among unvaccinated populations, and media coverage of the outbreak caused a flood of previously unvaccinated or uncertain adults and parents to seek MMR vaccination simultaneously.

Commercial pharmacies — CVS, Walgreens, and independent drugstores — stock vaccines based on forecasted routine demand. They are not sized for emergency surge demand. When large numbers of adults who had never received an MMR vaccine (many adults born before 1989 only received one dose, not two) showed up at once, shelves emptied quickly.

Historical Context: This Is Not the First Time

The 2025 shortage echoes a more serious event from 2001, when Merck — the sole U.S. manufacturer of M-M-R II at the time — voluntarily interrupted manufacturing operations, causing a genuine nationwide shortage of both MMR and varicella vaccines. The CDC was forced to issue interim ACIP recommendations prioritizing available doses for children and temporarily deferring catch-up vaccination for adults.

That 2001 shortage highlighted the risk of relying on a single manufacturer, which is one reason the FDA approved PRIORIX (GlaxoSmithKline) as an interchangeable alternative in 2022. Having two approved products on the market provides supply resilience that simply did not exist before.

Which Areas Were Most Affected?

The most acute shortages were reported in:

Texas — especially Austin and the Dallas-Fort Worth area, ground zero for the 2025 outbreak

New Mexico — particularly Lea County and the Permian Basin region

Massachusetts — urban areas including Boston suburbs reported CVS and Walgreens locations running out

Other states with measles cases — wherever outbreak news spread, demand surged locally

Even in affected areas, public health department clinics and pediatric offices enrolled in the Vaccines for Children (VFC) program generally maintained adequate stock, as they draw from government supply channels rather than commercial distributors.

Where Does MMR Vaccine Availability Stand Today?

Commercial pharmacy availability has improved in most regions as supply chains have had time to replenish. However, availability remains inconsistent. Some pharmacies are fully stocked while others in the same city may still be running low. The best approach remains to check multiple sources — pharmacy apps, your doctor's office, and health department clinics — before concluding that M-M-R II is unavailable in your area.

What Patients Should Do Right Now

Ask for PRIORIX if M-M-R II is unavailable — it is equally effective and FDA-approved as a full substitute.

Check your pediatrician's office and local health department first, especially for children — they are better stocked than commercial pharmacies during demand surges.

Do not delay vaccination — measles spreads quickly, and immunity is time-sensitive during an active outbreak.

Check multiple pharmacy chains using their websites or apps before calling — many show vaccine availability in real time.

How medfinder Helps During Shortages

During a shortage or demand surge, the hardest part is not knowing which of the pharmacies near you actually has stock. medfinder calls pharmacies in your area on your behalf, asking specifically about vaccine availability, and sends you the results by text. Instead of burning an afternoon on hold, you get answers fast.

For more on your vaccine alternatives, see: Alternatives to M-M-R II If You Can't Fill Your Prescription